Jiajia Tang

Dr. Jiajia Tang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Cell Reports
Verified
Journal Article
Open access
ECEnrico Caragliano
Enrico Caragliano
SBStefano Bonazza
Stefano Bonazza
GFGiada Frascaroli
Giada Frascaroli
JTJiajia Tang
Jiajia Tang
TSTimothy K. Soh
Timothy K. Soh
Wolfram BruneWolfram Brune
Wolfram Brune
Human cytomegalovirus (HCMV) replicates its DNA genome in specialized replication compartments (RCs) in the host cell nucleus. These membrane-less organelles originate as spherical structures and grow in size over time. However, the mechanism of RC biogenesis has remained understudied. Using live-cell imaging and photo-oligomerization, we show that a central component of RCs, the UL112-113 proteins, undergo liquid-liquid phase separation (LLPS) to form RCs in the nucleus. We show that the self-interacting domain and large intrinsically disordered regions of UL112-113 are required for LLPS. Importantly, viral DNA induces local clustering of these proteins and lowers the threshold for phase separation. The formation of phase-separated compartments around viral genomes is necessary to recruit the viral DNA polymerase for viral genome replication. Thus, HCMV uses its UL112-113 proteins to generate RCs around viral genomes by LLPS to ensure the formation of a pro-replicative environment.

19 August 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JTJiajia Tang
Jiajia Tang
GFGiada Frascaroli
Giada Frascaroli
RLRobert J. Lebbink
Robert J. Lebbink
EOEleonore Ostermann
Eleonore Ostermann
Wolfram BruneWolfram Brune
Wolfram Brune
Significance: Human cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and the most common infectious cause of birth defects. Although HCMV is not a generally accepted cause of cancer, it shares similarities to cancer-causing viruses: It dysregulates the cell cycle, activates the DNA damage response, and suppresses apoptosis. However, causes and consequences of these viral properties remain poorly understood. Here we show that HCMV activates caspase-2, an apoptosis-related enzyme activated by DNA damage and abnormal mitosis, in a strain-specific manner. Caspase-2 activation depends on envelope glycoprotein B variants with increased fusogenicity, which facilitate viral entry, promote cell fusion, and affect genome stability. These results suggest that specific glycoprotein B variants might affect HCMV transmission and pathogenicity.

31 August 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
XHXinyang Huang
Xinyang Huang
SHShenghui Huang
Shenghui Huang
CRChiara Reina
Chiara Reina
BŠBerina Šabanović
Berina Šabanović
MRMiriam Roberto
Miriam Roberto
CHChristopher Heeschen
Christopher Heeschen
Cancer stem cells (CSCs) are a subpopulation of tumor cells with self-renewal capacity and the ability to drive tumor growth, metastasis, and relapse. They are widely recognized as major contributors to therapeutic resistance. Despite extensive efforts to characterize and target CSCs, their elusive nature continues to drive therapeutic resistance and relapse in epithelial malignancies. Single-cell RNA sequencing (scRNA-seq) has transformed our understanding of tumor biology. It enables high-resolution profiling of rare subpopulations (<5%) and reveals the functional heterogeneity that contributes to treatment failure. In this review, we discuss evolving evidence for a paradigm shift, enabled by rapidly advancing single-cell technologies, from a static, marker-based definition of CSCs to a dynamic and functional perspective. We explore how trajectory inference and spatial transcriptomics redefine stemness by context-dependent dynamic-state modelling. We also highlight emerging platforms, including artificial intelligence-driven predictive modelling, multi-omics integration, and functional CRISPR screens. These approaches have the potential to uncover new vulnerabilities in CSC populations. Together, these advances should lead to new precision medicine strategies for disrupting CSC plasticity, niche adaptation, and immune evasion.

16 June 2023 in European Journal of Cancer
Verified
Journal Article
Closed access
QWQi Wang
Qi Wang
BŠBerina Šabanović
Berina Šabanović
AAAzhar Awada
Azhar Awada
CRChiara Reina
Chiara Reina
AAAlexandra Aicher
Alexandra Aicher
CHChristopher Heeschen
Christopher Heeschen

16 April 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
YZYaru Zhao
Yaru Zhao
CWChenlei Wen
Chenlei Wen
QWQi Wang
Qi Wang
YQYue Qing
Yue Qing
STSerena Tondi
Serena Tondi
CHChristopher Heeschen
Christopher Heeschen
Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge for early diagnosis due to the lack of sensitive and specific biomarkers. This encouraged us to explore the diagnostic value of cancer‐derived small extracellular vesicles (sEVs) as early detection biomarkers. We previously showed that the recombinant malaria protein VAR2CSA (rVAR2) selectively binds to oncofetal chondroitin sulfate (ofCS) on the surfaces of cancer cells, which might be useful for identifying cancer‐derived sEVs. Indeed, flow cytometry revealed strong ofCS expression in PDAC cell‐derived sEVs, as evidenced by the presence of mutant KRAS , a common genetic alteration in PDAC. Plasma from PDAC patients showed significantly higher ofCS + sEV levels compared to healthy donors and patients with benign gastrointestinal diseases. ROC analysis for ofCS + sEVs revealed an AUC of 0.9049 for the detection of all‐stage and 0.9222 for early‐stage PDAC. Notably, mutant KRAS was also detected in these patient‐derived sEVs. Most intriguingly, combining ofCS + sEVs and CA19‐9 resulted in an AUC of 0.9707 for the detection of early PDAC. Our study demonstrates that rVAR2 is suitable for detecting ofCS + cancer‐derived sEVs in plasma, thereby providing high efficiency for identifying PDAC patients among a diverse population. These findings suggest that rVAR2‐based sEV detection could serve as a powerful diagnostic tool to improve patient survival through early detection.

20 September 2011 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
TKT. Kong
T. Kong
XLX. B. Li
X. B. Li
GLGuowen Liu
Guowen Liu
GXG. H. Xie
G. H. Xie
ZWZhe Wang
Zhe Wang
JTJiajia Tang
Jiajia Tang